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Summary
  Endogenous morphine is present in the mammalian brain as determined by gas chromatography/mass 
spectrometry. The criteria essential for satisfying the defi nition of morphine as a neurotransmit-
ter are examined. The detection of endogenous morphine-like compounds inside brain neurons 
by immunocytochemistry and the Ca+ dependent release of endogenous morphine from rat brain 
slices provide evidence for its transmitter status. Indirect evidence that endogenous morphine 
modulates thermonociception and weakens memory through mu opioid receptors again supports 
a neurotransmitter role for this chemical messenger. Evidence has been found for its endogenous 
synthesis in animal tissues as well. These fi ndings indicate that endogenous morphine might func-
tion as neuromodulator/neurotransmitter agent in the CNS.
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BACKGROUND
A morphine-like material in animal tissues was originally dem-
onstrated by immunological recognition [1]. Subsequently, 
endogenous morphine-like compounds have been identifi ed 
in mouse and calf brain [2,3]. The molecular structure of 
the HPLC purifi ed compound was confi rmed as morphine 
by liquid and gas chromatographic retention times and mass 
spectrometry in various tissues such as bovine brain, rat and 
mouse brain, hypothalamus and adrenal glands, mammalian 
lung, invertebrate and human tissues, human cerebrospinal 
fl uid and human plasma [4–16]. Codeine and morphine also 
have been identifi ed in human cerebrospinal fl uid [14] and 
non human primate brain [17]. Morphine precursors, re-
ticuline [18], thebaine [19] and codeine [20–22] are some 
of the main intermediates of morphine biosynthesis in the 
poppy plant and have been found in mammals.
The pathway for morphine biosynthesis has been established 
in the opium poppy and animal tissue. In this regard, ra-
diolabeled reticuline was transformed into salutaridine by 
rat liver microsomes in vitro and a similar conversion has 
been observed in vivo [23]. The conversion of salutarid-
ine, thebaine and codeine into morphine has been dem-
onstrated in several rat tissues, including the brain, provid-
ing evidence for the biosynthetic pathway of endogenous 
morphine (eM) in mammals [5,24]. Incubation of human 
neural cancer cell lines with L-tyrosine leads to the forma-
tion of morphine as well [25]. Addition of reticuline to in-
tact invertebrate ganglia in vivo leads to the formation of 
morphine [26]. Ascaris suum, a mammalian parasite pro-
duces morphine in mammalian hosts and in vitro, a phe-
nomenon that may dull the host discomfort so that the par-
asite can escape host surveillance [27].
IMMUNOCYTOCHEMICAL LOCALIZATION OF ENDOGENOUS 
MORPHINE IN MAMMALIAN BRAIN
Morphine-like immunoreactivity has been demonstrated in 
cell bodies, fi bers and terminals of neurons in different brain 
areas of the rat [28], mouse [2] and man [29] by indirect im-
munofl uorescence and unlabeled antibody enzyme procedure. 
The antisera revealed numerous nerve cell bodies with variable 
morphology, dendrites and nerve fi bers throughout the cere-
bral cortex. In the caudate putamen numerous medium size 
immunoreactive perikaria were visible. Nerve cell body and fi b-
ers were stained in the hyppocampal formation; dot-like immu-
noreactivity was visible around granule cells of dentate gyrus 
and dorsal hippocampus; immunoreactive nerve cell bodies 
were also revealed throughout the brainstem. In the cerebel-
lum numerous granule cells in the granular layer and small 
neurons and fi bers in the molecular layer are immunoreactive. 
In human brain tissue, morphine-like immunoreactivity was 
identifi ed in cerebral and cerebellar cortex. Morphine positive 
terminals were observed in rat hyppocampal formation some-
times forming synaptic contact with the soma of unlabeled cells 
[29]. In different regions of the brainstem positive morphine-
like nerve fi bers apposed to µ opiate receptor (µOR) immu-
noreactive cell bodies were observed (Figure 1).
MORPHINE RELEASE
Neurotransmitters and neuromodulators are released from 
neurons by depolarization in a Ca++ dependent manner. 
Neuron depolarization by high potassium concentrations 
caused the release of endogenous morphine from eel chro-
maffi n cells [20]. The release of endogenous morphine 
from rat brain slices was observed in vitro in the presence 
of high potassium concentration; this effect disappeared 
when Ca++ was omitted from the superfusion medium [7]. 
Furthermore, exogenously applied morphine can affect the 
release of other neurotransmitters, i.e., dopamine, in nerv-
ous tissues suggesting a similar role for endogenous mor-
phine [30].
MORPHINE UPTAKE
The slow i.c.v. infusion of [3H]morphine demonstrated 
the capacity of specifi c brain neurons to store the alkaloid 
[28]. Otherwise synaptosomes from mid-brain, cerebral cor-
tex and cerebellum failed to take up and store any trace of 
the tritiated alkaloid [28]. However, this fi nding also sug-
gests that an alternate degradation process may be operat-
ing. The major pathway for the detoxication of exogenous 
morphine is conversion of morphine to morphine 6 glu-
curonide and/or morphine 3 glucuronide. The presence 
of morphine 6-dehydrogenase in mammalian liver [31] sug-
gests the metabolic pathway of morphine to morphinone 
as a route in endogenous morphine metabolism. Thus, en-
dogenous morphine conversion may represent the way to 
terminate its action.
ROLE OF ENDOGENOUS MORPHINE IN THE MODULATION OF 
THERMAL NOCICEPTION
The depletion of endogenous morphine in mouse brain 
was obtained by immunoneutralization of this molecule 
from brain extracellular spaces. An affi nity purifi ed anti-
morphine IgG was administered to mice, which then un-
derwent the hot plate test. As shown by the licking latency 
in the hot plate test, the nociceptive threshold in response 
to thermal stimulus was signifi cantly lowered by anti-mor-
phine IgG with respect to controls. We attributed this ef-
fect to a decrease in endogenous morphine levels present 
in mouse brain extracellular spaces [8]. Endogenous mor-
phine depletion attenuated the antinociceptive effect of the 
mu selective agonist DAMGO in the hot plate test where-
as enkephalin or DPDE antinociceptive effect was unmodi-
fi ed [8]. Therefore, endogenous morphine appears to be 
involved in the modulation of thermonociception in mice 
via the µOR receptor [8].
ROLE OF ENDOGENOUS MORPHINE IN WEAKENING MEMORY 
PROCESSES UNDER STRESS CONDITION
Classically, exogenous morphine administration impairs 
memory processes [32] and a highly signifi cant regres-
sion coeffi cient between analgesia and memory impair-
ment was found after opiate administration [33]. Twelve 
hour food deprivation (fasting) induced a stress condition, 
which does not interfere with motor coordination, sponta-
neous motility and exploratory activity. An anti-morphine 
IgG was administered to mice in order to induce morphine 
depletion in extracellular spaces. Fed and stressed animals 
were both administered with anti-morphine IgG and sub-
mitted to passive avoidance test to study the effect of endog-
enous morphine depletion on working memory [34]. Fed 
animals were used as a control. Acquisition and consolida-
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tion of memory was signifi cantly impaired in stressed an-
imals with respect to control. This was demonstrated by a 
decrease in entry latency into the dark room in the reten-
tion session of the passive avoidance test. This effect was re-
versed to the basal value after endogenous morphine deple-
tion. Therefore, endogenous morphine may be involved in 
weakening memory processes under stress conditions [34]. 
This may provide a strategy for limiting future hesitancy 
when action is called for.
MU RECEPTOR INTERACTION: POSTSYNAPTIC RESPONSE 
SYSTEM
Recently the µ3OR has been cloned in human neural (cell 
line), immune and vascular tissues [35]. This µ3OR splice var-
iant is morphine selective and opioid peptide insensitive and 
is coupled to nitric oxide release [36]. In rat limbic tissues 
(hippocampus and amygdala) morphine is present as dem-
onstrated by biochemical, including mass spectrometry, and 
immunocytochemical techniques [28,37,38]. Additionally, 
adding exogenous morphine to these tissues results in con-
stitutive nitric oxide release, which does not occur with opi-
oid peptides, indirectly demonstrating the µ3OR subtype 
[36]. Taken together, a highly specifi c postsynaptic recep-
tor exists in these tissues for morphine.
Criteria for defi ning a chemical messenger as a neurotrans-
mitter exists. These criteria are the following: 1) The chemi-
cal must be produced and found within a neuron; 2) When a 
neuron is depolarized, it must release the chemical in a Ca++ 
dependent manner; 3) When released, the chemical messen-
ger must act on a post-synaptic receptor and cause a biolog-
ical effect; 4) After exerting its action, the chemical messen-
ger must be inactivated via a reuptake mechanism or by an 
enzyme that terminates its action; and lastly, 5) If the chem-
ical messenger is applied on the post-synaptic membrane, it 
should have the same effect as when it is released by a neu-
ron. Taken together, the earlier noted studies demonstrate 
that morphine functions as a neurotransmitter.
CONCLUSIONS
Reticuline [18], thebaine [19] and codeine [12,20,38] are 
some of the main intermediates of morphine biosynthesis 
in the poppy plant and these compounds have been found 
in mammals and invertebrates, especially in their neural tis-
sues. Radiolabeled reticuline was transformed into salutarid-
ine by rat liver microsomes in vitro and a similar conversion 
has been observed in vivo [23]. The conversion of salutari-
dine, thebaine and codeine into morphine has been dem-
onstrated in several rat tissues, including the brain, provid-
ing evidence for the biosynthetic pathway of endogenous 
morphine in mammals [5,24]. Reticuline exposure to inver-
tebrate ganglia leads to morphine formation as well [26]. 
Presently morphine appears to be endogenously synthe-
sized by brain microsomes even if microsomes are intrac-
ellular membrane structures belonging to different brain 
cell type. In a neural cancer cell line L-tyrosine exposure 
leads to morphine formation [25]. Morphine immunore-
activity has been demonstrated inside the cell body, fi bers 
and terminals of neurons in different brain areas of the 
rat [28], mouse [2], humans [29] and invertebrate neural 
tissues [39]. We also have demonstrated that endogenous 
morphine can be released in a chemically detectable form 
from rat brain slices in a Ca2+ and K+ dependent manner, 
fulfi lling a criterion for endogenous morphine as a neuro-
transmitter [12]. When endogenous morphine was deplet-
ed from mice brain extracellular spaces, acute thermono-
ciception was increased and working memory weakness, a 
classic effect of exogenous morphine administration, was 
impaired [8,34]. Both these effects appeared to be mediat-
ed through µOR. We failed to observe an active uptake of 
[3H]morphine by rat brain synaptosomes [28]. However, 
its enzymatic conversion to different metabolites may satis-
fy this criterion. A novel µ3OR exists, which is coupled to ni-
tric oxide release and only responds to morphine. This oc-
curs in both human, mammalian and invertebrate tissues. 
Endogenous morphine and the µ receptor are associated 
throughout the phylogenesis of the nerve system of mam-
mal and lower animals, suggesting that this molecule is a 
physiological ligand of the µ receptor.
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